SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,091 | +43.4% | 42 | +35.5% | 0.00% | – |
Q2 2023 | $3,550 | -35.6% | 31 | -22.5% | 0.00% | -100.0% |
Q1 2023 | $5,513 | +52.0% | 40 | +42.9% | 0.00% | – |
Q4 2022 | $3,628 | -39.5% | 28 | -44.0% | 0.00% | -100.0% |
Q3 2022 | $6,000 | +50.0% | 50 | +2.0% | 0.00% | 0.0% |
Q4 2021 | $4,000 | -20.0% | 49 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $5,000 | +400.0% | 49 | +600.0% | 0.00% | – |
Q2 2021 | $1,000 | -50.0% | 7 | -36.4% | 0.00% | – |
Q4 2020 | $2,000 | -89.5% | 11 | -92.7% | 0.00% | -100.0% |
Q4 2019 | $19,000 | -17.4% | 150 | -50.0% | 0.01% | -22.2% |
Q3 2019 | $23,000 | -34.3% | 300 | 0.0% | 0.01% | -35.7% |
Q1 2019 | $35,000 | – | 300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 1,010,330 | $122,472,203 | 13.56% |
Finepoint Capital LP | 145,357 | $17,620,176 | 8.78% |
Avoro Capital Advisors LLC | 4,025,000 | $487,910,500 | 7.61% |
Saturn V Capital Management LP | 118,401 | $14,352,569 | 6.01% |
Ghost Tree Capital, LLC | 150,000 | $18,183,000 | 5.98% |
Ikarian Capital, LLC | 3,673 | $44,524,106 | 5.36% |
ACUTA CAPITAL PARTNERS, LLC | 550 | $7,580,650 | 5.08% |
Eagle Health Investments LP | 174,212 | $21,117,979 | 4.65% |
Boxer Capital, LLC | 600,000 | $72,732,000 | 3.87% |
GREAT POINT PARTNERS LLC | 165,200 | $20,025,544 | 3.65% |